Skip to content
Clinical Trials – home

Gelre Hospitals

Verified siteinfo

The Netherlands Den Elterweg 77, 7207 AE Zutphen, The Netherlands

  • 7 trials recruiting
  • Chronic obstructive pulmonary disease · Bronchiectasis · Heart failure with reduced ejection fraction
  • Adults and children

About Specializations

Gelre Hospitals in Zutphen, The Netherlands specialises in clinical trials of conditions such as Chronic obstructive pulmonary disease, Bronchiectasis, Heart failure with reduced ejection fraction, Asthma, and other specialisations. This site conducts important research.

Main research areas of the site

Cardiovascular Disease and Heart Failure

At Gelre Hospitals in Zutphen, a major focus is on cardiovascular research, with studies addressing atherosclerotic cardiovascular disease, myocardial infarction, atrial fibrillation, and heart failure with reduced ejection fraction. These trials aim to test new treatments, improve prevention, and reduce the risk of serious heart-related events.

  • Testing therapies to lower the risk of heart attack, stroke, and other major cardiovascular events
  • Evaluating new approaches for heart failure after myocardial infarction
  • Studying better prevention of thromboembolism and bleeding in patients with atrial fibrillation

The site’s Research Cardiologie department supports work that aims to improve long-term outcomes for patients with common and high-risk cardiovascular diseases.

Oncology and Hematologic Malignancies

The trial portfolio includes a strong emphasis on cancer research, especially lymphoma, breast cancer, lung cancer, esophageal cancer, prostate cancer, and multiple myeloma. Research at this hospital is focused on testing new treatment combinations, improving disease control, and extending survival in both solid tumors and blood cancers.

  • Evaluating novel treatment strategies for diffuse large B-cell lymphoma, follicular lymphoma, and other non-Hodgkin lymphomas
  • Studying new options for advanced breast cancer, including HER2-positive and hormone receptor-positive disease
  • Assessing therapies for advanced non-small cell lung cancer and esophageal cancer
  • Exploring personalized treatment for multiple myeloma and other advanced cancers

Much of this work aims to improve treatment effectiveness while also reducing toxicity and supporting more individualized cancer care.

Respiratory Diseases and Infectious Conditions

Clinical studies in respiratory medicine and infection-related disease cover COPD, asthma, bronchiectasis, idiopathic pulmonary fibrosis, pneumonia, influenza, and respiratory syncytial virus infections. The purpose is often to test better symptom control, reduce exacerbations, and improve recovery in patients with complex lung disease or serious infections.

  • Testing treatments to reduce flare-ups in chronic obstructive pulmonary disease and severe asthma
  • Studying new ways to manage bronchiectasis, idiopathic pulmonary fibrosis, and chronic cough
  • Evaluating therapies for pneumonia, influenza, and acute respiratory distress syndrome
  • Improving care for patients with difficult-to-treat respiratory infections

These studies reflect a broad interest in both long-term respiratory disease management and acute pulmonary illness.

Kidney Disease, Metabolic Disorders, and Cardiorenal Risk

Research also covers chronic kidney disease, end-stage kidney disease, obesity, overweight, severe hypertriglyceridemia, and related metabolic disorders. The main goal is to evaluate treatments that may protect kidney function, improve metabolic health, and lower the risk of cardiovascular complications.

  • Assessing therapies for chronic kidney disease and end-stage kidney disease
  • Studying treatments that may improve lipid disorders and metabolic risk
  • Exploring options to reduce combined cardiac and renal events in high-risk patients

This area links kidney care with broader prevention of serious cardiovascular and metabolic complications.

Neurology, Stroke Prevention, and Ear Disorders

Several studies focus on neurological and vascular conditions such as ischemic stroke, transient ischemic attack, chronic subdural hematoma, and Menière's disease. The research is designed to improve prevention, reduce recurrence, and support better symptom control in patients with disabling neurological or balance-related disorders.

  • Testing strategies to prevent recurrent stroke and systemic embolism
  • Evaluating treatments for chronic subdural hematoma to reduce the need for surgery
  • Studying symptom relief in Menière's disease and related vestibular complaints

These trials aim to improve both safety and daily functioning for patients affected by cerebrovascular and neurologic disease.

Musculoskeletal, Pain, and Reconstructive Care

Another important area includes musculoskeletal and pain-related research, with studies in chronic pancreatitis pain, postoperative pain, polymyalgia rheumatica, and joint prosthesis infection. The goal is to find better ways to relieve pain, reduce complications, and improve recovery after procedures or surgery.

  • Evaluating pain control strategies after breast cancer surgery and in chronic pancreatitis
  • Studying treatment approaches for polymyalgia rheumatica to improve disease management
  • Comparing infection treatments for prosthetic joint infection

Work in this area supports more effective symptom relief and safer recovery across a range of musculoskeletal and postoperative conditions.

Women's Health, Fertility, and Urogenital Disorders

Clinical trials also address fertility, reproductive health, and urogenital disorders, including infertility, uterine fibroids, vulvar high-grade squamous intraepithelial lesion, and female urogenital complications. These studies aim to improve reproductive outcomes, prevent recurrence, and support better care for women with gynecologic conditions.

  • Testing ways to improve live birth rates in fertility treatment
  • Evaluating prevention of recurrence in vulvar HSIL
  • Studying management options for uterine fibroids and other reproductive disorders

This research reflects a practical focus on both fertility support and the treatment of common gynecologic conditions.

Diagnostics, Anesthesia, and Perioperative Care

Some trials at this site concentrate on diagnostic procedures, sedation, and perioperative management. These studies are designed to improve patient comfort, recovery, and procedural safety in everyday hospital care.

  • Comparing sedation options for upper gastrointestinal endoscopy
  • Evaluating nerve block techniques for mastectomy surgery
  • Studying ways to improve outcomes around surgical care and diagnostic procedures

Although smaller in scope than the cardiology and oncology programs, this work supports better hospital-based care and a smoother patient experience.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Site location
Den Elterweg 777207 AE ZutphenThe Netherlands
Recruiting now
7 trials
Conditions studied
19
Partner status
Verified site

More sites in ZutphenThe Netherlands

Recruiting now

Ongoing trials

Clinical trials currently enrolling participants at this site.

Condition
Type of trial
Recruitment status
Quick filters

25 clinical trials

Study of lunsekimig versus placebo in adults with inadequately controlled eosinophilic COPD

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Lunsekimig
  • Sponsor:Sanofi-Aventis Recherche & Developpement

Asthma

Recruiting

A Study of Brenipatide Compared to Placebo for Adults with Uncontrolled Moderate to Severe Asthma

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years
  • Substances:LY3537031
  • Sponsor:Eli Lilly & Co.

Bronchiectasis

Recruiting

Study of BI 1291583 tablets taken once daily for 76 weeks in adults with bronchiectasis

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:BI 1291583
  • Sponsor:Boehringer Ingelheim Espana S.A.

Effect of elecoglipron plus dapagliflozin on cardiovascular outcomes in adults with heart failure with preserved or mildly reduced ejection fraction (HFpEF/HFmrEF)

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:AZD5004
  • Sponsor:AstraZeneca AB

Bronchiectasis

Recruiting

A study to evaluate the safety and effectiveness of AZD0292 in people aged 12 years and older with bronchiectasis and chronic Pseudomonas aeruginosa infection

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:AZD0292
  • Sponsor:AstraZeneca AB

A Study of Depemokimab Compared to Placebo in Adults with Chronic Obstructive Pulmonary Disease and Type 2 Inflammation

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited

Study of Tezepelumab in Adults with Moderate to Very Severe Chronic Obstructive Pulmonary Disease (COPD) to Reduce Disease Flare-ups

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Tezepelumab
  • Sponsor:AstraZeneca AB

Evaluating the efficacy and safety of CRD-4730 in patients with heart failure with reduced ejection fraction

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:CRD-4730
  • Sponsor:Cardurion Pharmaceuticals Inc.

A study to evaluate the safety and effectiveness of zampilimab in people with idiopathic pulmonary fibrosis

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Zampilimab
  • Sponsor:Chiesi Farmaceutici S.p.A.

Bronchiectasis

Not yet recruiting

Study of Nebulized Human Normal Immunoglobulin (CSL787) for Adults with Non-cystic Fibrosis Bronchiectasis to Find Best Dose and Test Safety

Investigational
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Human Normal Immunoglobulin
  • Sponsor:CSL Behring LLC

Asthma

Not recruiting

Study on the Safety of CHF5993 Inhaler with HFA-152a vs. HFA-134a in Patients with Moderate to Severe Asthma

Registered drugNo placebo
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:Chiesi Farmaceutici S.p.A.

A study testing tozorakimab for long-term treatment of chronic obstructive pulmonary disease in former smokers with repeated flare-ups

Registered drug
Countries:The NetherlandsThe Netherlands
  • Participants:18–64 years · 65+ years
  • Substances:Salbutamol
  • Sponsor:AstraZeneca AB
Is this your site?

Join our network of research sites

Move up to Verified & featured: your own description, photos and phone number on this page, and top placement on every trial you run.

See the offer for sites
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.